The CRAFITY score: A promising prognostic predictor for patients with hepatocellular carcinoma treated with tyrosine kinase inhibitor and immunotherapy combinations

被引：23

作者：

Yang, Yi ^{[1
,2
,3
]}

Ouyang, Jingzhong ^{[4
]}

Zhou, Yanzhao ^{[4
]}

Zhou, Jinxue ^{[4
]}

Zhao, Hong ^{[1
,2
,3
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Hepatobiliary Surg, Natl Canc Ctr, Canc Hosp,Natl Clin Res Ctr Canc, Beijing, Peoples R China

[2] Chinese Acad Med Sci & Peking Union Med Coll, Key Lab Gene Editing Screening & Res, Beijing, Peoples R China

[3] Chinese Acad Med Sci & Peking Union Med Coll, Dev R&D Digest Syst Tumor Drugs, Beijing, Peoples R China

[4] Zhengzhou Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷 / 02期

基金：

中国国家自然科学基金;

关键词：

D O I：

10.1016/j.jhep.2022.03.018

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：574 / 576

页数：3

共 50 条

[1] Vessels that encapsulate tumor clusters (VETC): A promising prognostic predictor for patients with hepatocellular carcinoma treated with tyrosine kinase inhibitor and immunotherapy combinations
Yin, Y.
Zhang, W.
Wei, Z.
Che, X.
Bi, X.
ANNALS OF ONCOLOGY, 2024, 35 : S660 - S660
[2] Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score
Scheiner, Bernhard
Pomej, Katharina
Kirstein, Martha M.
Hucke, Florian
Finkelmeier, Fabian
Waidmann, Oliver
Schulze, Kornelius
Koch, Sandra
Spahn, Stephan
Radu, Pompilia
Siebenhuener, Alexander R.
Mertens, Joachim C.
Rahbari, Nuh N.
Kuetting, Fabian
Waldschmidt, Dirk-Thomas
Ebert, Matthias P.
Teufel, Andreas
De Dosso, Sara
Pinato, David J.
Pressiani, Tiziana
Meischl, Tobias
Balcar, Lorenz
Mueller, Christian
Reiberger, Thomas
Trauner, Michael
Personeni, Nicola
Rimassa, Lorenza
Bitzer, Michael
Trojan, Jorg
Weinmann, Arndt
Wege, Henning
Dufour, Jean-Francois
Peck-Radosavljevic, Markus
Vogel, Arndt
Pinter, Matthias
WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 5) : 179 - 179
[3] Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy-the CRAFITY score
Scheiner, Bernhard
Pomej, Katharina
Kirstein, Martha M.
Hucke, Florian
Finkelmeier, Fabian
Waidmann, Oliver
Schulze, Kornelius
Koch, Sandra
Spahn, Stephan
Radu, Iuliana Pompilia
Siebenhuener, Alexander
Mertens, Joachim C.
Rahbari, Nuh N.
Kuetting, Fabian
Waldschmidt, Dirk-Thomas
Ebert, Matthias
Teufel, Andreas
De Dosso, Sara
Pinato, David J.
Pressiani, Tiziana
Meischl, Tobias
Balcar, Lorenz
Mueller, Christian
Reiberger, Thomas
Trauner, Michael
Personeni, Nicola
Rimassa, Lorenza
Bitzer, Michael
Trojan, Joerg
Weinmann, Arndt
Wege, Henning
Dufour, Jean-Francois
Peck-Radosavljevic, Markus
Vogel, Arndt
Pinter, Matthias
JOURNAL OF HEPATOLOGY, 2021, 75 : S236 - S238
[4] Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?
Guan, Renguo
Mei, Jie
Lin, Wenping
Deng, Min
Li, Shaohua
Guo, Rongping
HEPATOLOGY INTERNATIONAL, 2023, 17 (05) : 1279 - 1288
[5] Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score
Scheiner, Bernhard
Pomej, Katharina
Kirstein, Martha M.
Hucke, Florian
Finkelmeier, Fabian
Waidmann, Oliver
Himmelsbach, Vera
Schulze, Kornelius
von Felden, Johann
Frundt, Thorben W.
Stadler, Marc
Heinzl, Harald
Shmanko, Kateryna
Spahn, Stephan
Radu, Pompilia
Siebenhuener, Alexander R.
Mertens, Joachim C.
Rahbari, Nuh N.
Kuetting, Fabian
Waldschmidt, Dirk-Thomas
Ebert, Matthias P.
Teufel, Andreas
De Dosso, Sara
Pinato, David J.
Pressiani, Tiziana
Meischl, Tobias
Balcar, Lorenz
Mueller, Christian
Mandorfer, Mattias
Reiberger, Thomas
Trauner, Michael
Personeni, Nicola
Rimassa, Lorenza
Bitzer, Michael
Trojan, Joerg
Weinmann, Arndt
Wege, Henning
Dufour, Jean-Francois
Peck-Radosavljevic, Markus
Vogel, Arndt
Pinter, Matthias
JOURNAL OF HEPATOLOGY, 2022, 76 (02) : 353 - 363
[6] Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?
Renguo Guan
Jie Mei
Wenping Lin
Min Deng
Shaohua Li
Rongping Guo
Hepatology International, 2023, 17 : 1279 - 1288
[7] Prognostic significance of the CRAFITY score in hepatocellular carcinoma treated with immunotherapy: a systematic review and meta-analysis
Yang, Ming
Pan, Yilin
Wang, Wentao
BMC CANCER, 2023, 23 (01)
[8] Prognostic significance of the CRAFITY score in hepatocellular carcinoma treated with immunotherapy: a systematic review and meta-analysis
Ming Yang
Yilin Pan
Wentao Wang
BMC Cancer, 23
[9] Validation of the CRAFITY score in patients with hepatocellular carcinoma treated with atezolizumab and bevacizumab
Scheiner, Bernhard
Sartoris, Riccardo
D'Alessio, Antonio
Fulgenzi, Claudia
Pomej, Katharina
Balcar, Lorenz
Bouattour, Mohamed
Sidali, Sabrina
Himmelsbach, Vera
Finkelmeier, Fabian
Schulze, Kornelius
von Felden, Johann
Hucke, Florian
Shmanko, Kateryna
Siebenhuner, Alexander
Mertens, Joachim C.
De Dosso, Sara
Ebert, Matthias
Teufel, Andreas
Waldschmidt, Dirk-Thomas
Radu, Iuliana Pompilia
Krall, Anja
Trauner, Michael
Dufour, Jean-Francois
Wege, Henning
Weinmann, Arndt
Trojan, Joerg
Stauber, Rudolf E.
Peck-Radosavljevic, Markus
Hsu, Wei-Fan
Vogel, Arndt
Ronot, Maxime
Pinato, David J.
Pinter, Matthias
JOURNAL OF HEPATOLOGY, 2023, 78 : S491 - S492
[10] Assessing Prognosis in Hepatocellular Carcinoma in The Era Of Immunotherapy - The CRAFITY Score
Panigrahi, Manas Kumar
Anirvan, Prajna
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (02) : 643 - +

← 1 2 3 4 5 →